| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 33.044 | 46.569 | 262.123 | 255.757 | 222.948 | 371.670 | 337.488 |
| Total Income - EUR | - | - | - | 33.044 | 46.569 | 262.123 | 255.757 | 222.948 | 372.183 | 337.488 |
| Total Expenses - EUR | - | - | - | 20.614 | 33.391 | 247.977 | 234.129 | 210.632 | 365.488 | 367.082 |
| Gross Profit/Loss - EUR | - | - | - | 12.430 | 13.178 | 14.145 | 21.629 | 12.317 | 6.696 | -29.594 |
| Net Profit/Loss - EUR | - | - | - | 12.100 | 12.621 | 13.041 | 19.583 | 10.556 | 3.610 | -29.594 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
Check the financial reports for the company - B Androlact S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 3.245 | 2.404 | 23.399 | 17.917 | 12.326 | 7.446 |
| Current Assets | - | - | - | 91.377 | 21.988 | 34.270 | 56.632 | 71.026 | 52.425 | 74.858 |
| Inventories | - | - | - | 85.688 | 19.590 | 27.608 | 51.421 | 68.561 | 10.792 | 27.595 |
| Receivables | - | - | - | 0 | 2.030 | 987 | 3.362 | 491 | 35.964 | 39.322 |
| Cash | - | - | - | 5.689 | 368 | 5.676 | 1.849 | 1.975 | 5.669 | 7.941 |
| Shareholders Funds | - | - | - | 12.143 | 24.529 | 25.464 | 39.549 | 37.048 | -10.886 | -64.543 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 79.235 | 704 | 11.211 | 40.481 | 51.896 | 75.636 | 146.847 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5210 - 5210" | |||||||||
| CAEN Financial Year |
5210
|
|||||||||
Comments - B Androlact S.r.l.